A new study by Weill Cornell Medicine and Oregon Health & Science University sheds light on developing a vaccine to block cytomegalovirus (CMV) transmission from mother to fetus. CMV, a widespread virus, can cause severe birth defects and long-term health issues in newborns.
Researchers found that removing a previously targeted viral protein did not prevent transmission, indicating the need for new vaccine targets. Despite decades of research, no effective CMV vaccine exists, underscoring the urgency of this work.
Future studies will focus on virus-host interactions to refine vaccine development.
FingerLakes1.com is the region’s leading all-digital news publication. The company was founded in 1998 and has been keeping residents informed for more than two decades. Have a lead? Send it to [email protected].